引进国际创新药械 海南乐城加快构建医药产业生态圈

Group 1 - The core viewpoint of the article highlights the efforts of the Boao Lecheng International Medical Tourism Pilot Zone in accelerating the development of a comprehensive pharmaceutical industry ecosystem through various initiatives, including the introduction of international innovative drugs and medical devices, local production, and the establishment of research and transformation platforms [1][2] Group 2 - The Lecheng Pilot Zone has introduced over 470 types of special drugs and medical devices through a green channel for real-world research, facilitating the registration and market entry of 21 products in China [1] - The "Lecheng + Haikou production" model has enabled the local production and approval of imported drugs, such as "Kisqali," which is set to commence production in Haikou National High-tech Zone in April 2024 [1] - The Pilot Zone has established partnerships with over 180 pharmaceutical and medical device companies from 20 countries, attracting major firms like Merck, Sonova, Gilead, Novartis, and others to set up R&D, trade, and production operations in Hainan [2] Group 3 - The Pilot Zone is enhancing its research capabilities by gathering high-quality medical resources and serving as a regulatory science research base for the National Medical Products Administration, with 30 medical institutions already operational [2] - An investment of nearly 1 billion yuan is being made to complete the Lecheng Medical Engineering Transformation Platform by the end of this year, which will be the first technology transfer and incubation platform in the innovative drug and medical device sector in Hainan [2] - The total scale of industry funds in the Lecheng Pilot Zone has reached 882 million yuan, supported by the successful introduction of three funds, including the Hainan Tourism Investment Health Industry Fund and the Lecheng Digital Therapy Fund [2]